Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy

Italiano, A., Garbay, D., Cioffi, A., Maki, R. G., Bui, B. (August 2012) Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy. Ann Oncol, 23 (8). pp. 2205-6. ISSN 1569-8041 (Electronic)0923-7534 (Linking)

URL: https://www.ncbi.nlm.nih.gov/pubmed/22833275
DOI: 10.1093/annonc/mds219

Abstract

Pleomorphic liposarcoma (PLPS) is the less common subtype of liposarcoma, accounting for only 5%–15% of all liposarcomas and characterized by a high malignant potential with metastases in 30%–35% of cases [1]. Data regarding the role of systemic treatment in patients with advanced PLPS are almost nonexistent. We reviewed the medical records of 39 patients with unresectable and/or metastatic PLPS who were treated between 1991 and 2011.

Item Type: Paper
Uncontrolled Keywords: Adult Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Disease-Free Survival Female Humans Liposarcoma/*drug therapy/pathology/surgery Male Middle Aged Survival Rate Treatment Outcome
Subjects: diseases & disorders > cancer > drugs and therapies > chemotherapy
diseases & disorders > cancer > drugs and therapies
diseases & disorders > cancer > cancer types > sarcoma
CSHL Authors:
Communities: CSHL labs > Maki lab
Depositing User: Matt Covey
Date: August 2012
Date Deposited: 21 Oct 2016 14:59
Last Modified: 21 Oct 2016 14:59
Related URLs:
URI: http://repository.cshl.edu/id/eprint/33735

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving